Toll-like receptors (TLRs) shape innate and adaptive immunity to microorganisms. The enzyme IRAK1 transduces signals from TLRs, but mechanisms for its activation and regulation remain unknown. We found here that TLR7 and TLR9 activated the isomerase Pin1, which then bound to IRAK1; this resulted in activation of IRAK1 and facilitated its release from the receptor complex to activate the transcription factor IRF7 and induce type I interferons. Consequently, Pin1-deficient cells and mice failed to mount TLR-mediated, interferon-dependent innate and adaptive immune responses. Given the critical role of aberrant activation of IRAK1 and type I interferons in various immune diseases, controlling IRAK1 activation via inhibition of Pin1 may represent a useful therapeutic approach.
A r t i c l e s
Toll-like receptors (TLRs) recognize distinct pathogen-associated molecular patterns and elicit signaling cascades, which leads to upregulation of type I interferons and proinflammatory cytokines that orchestrate innate and adaptive immunity to infection [1] [2] [3] . In particular, intracellular TLRs are involved mainly in the recognition of viral antigens (TLR3 and TLR7), as well as viral and bacterial antigens (TLR9), and are especially adept at triggering type I interferon immune responses [4] [5] [6] [7] . Although ligation of TLR3 induces activation of the transcription factor IRF3 and subsequent secretion of interferon-β (IFN-β) that is independent of the adaptor MyD88 but dependent on the adaptor TRIF, the TLR9 subfamily members TLR7 and TLR9 exclusively use MyD88, which leads to robust production of type I interferon mainly from plasmacytoid dendritic cells (pDCs) 2, 8 . Type I interferons are essential for antiviral immune responses, as they induce various interferon-inducible genes and promote the cytotoxicity of natural killer cells, the maturation of dendritic cell (DCs) and the differentiation of virus-specific cytotoxic T lymphocytes, thereby linking innate and adaptive immunity [1] [2] [3] 9 . However, TLR activation is a 'double-edged sword' , as inappropriate activation can result in pathological inflammation and disease 10, 11 .
An essential molecule that transduces signals from the upstream receptor complex for most TLRs to downstream transcription factors is the enzyme IRAK1 (interleukin 1 (IL-1) receptor-associated kinase 1) [12] [13] [14] . After ligation of the TLR, IRAK1 is recruited to the TLR complex that contains MyD88, IRAK4 and the adaptor TRAF6, where IRAK4 phosphorylates IRAK1; this promotes autophosphorylation of IRAK1, which leads to a characteristic shift in mobility of ~20 kilodaltons (kDa) as it migrates through SDScontaining gels, a hallmark of IRAK activation. Activated IRAK1 dissociates from the receptor complex to activate the transcription factor IRF7 for the induction of type I interferons [12] [13] [14] [15] [16] [17] [18] [19] . IRAK1-deficient mice have a blunted inflammatory response to ligation of TLR2 and TLR4 (ref. 20) , but perhaps their most important phenotype is the complete loss of IFN-α secretion after ligation of TLR7 or TLR9 (ref. 14) . Although autophosphorylation of IRAK1 is suggested to be key event in TLR signaling 12, 13, 17 , little is known about how such phosphorylation leads to IRAK1 activation and whether there is further regulation after phosphorylation.
Phosphorylation of serine or threonine residues that precede a proline residue (Ser/Thr-Pro) is a central signaling mechanism in many cellular processes under both physiological and pathological conditions 21 . Phosphorylated Ser/Thr-Pro motifs exist in two distinct conformations, cis and trans, whose interconversion rate is much lower after phosphorylation but is specifically accelerated by the prolyl isomerase Pin1, the only known phosphorylation-specific isomerase 22 . Pin1 has two structurally and functionally distinct domains: a WW domain that binds phosphorylated Ser/Thr-Pro, and a catalytic peptidyl-prolyl-cis-trans-isomerase (PPIase) domain that isomerizes phosphorylated Ser/Thr-Pro. Pin1 controls the function of many key regulators in various cellular processes, and its deregulation contributes to the pathogenesis of various diseases 21 .
Pin1 acts on IRF3 to affect IFN-β production after stimulation of TLR3 or activation of the helicase RIG-I 23 . However, unlike IRF3-or TLR3-deficient mice, IRF7-or IRAK1-deficient mice completely fail A r t i c l e s to mount type I interferon antiviral responses because of the loss of secretion of type I interferons from pDCs 19, 24 . Such findings compelled us to examine the role of Pin1 in other TLR signal pathways. We found that Pin1 was a regulator of IRAK1 activation in TLR signaling and type I interferon-mediated innate and adaptive immunity. Inhibitors of Pin1, which are under development 21, 25 , may be useful in allowing selective inhibition of the type I interferon response while leaving proinflammatory cytokine production unaffected.
RESULTS

Pin1 is essential for TLR-induced secretion of type I interferon
To examine the role of Pin1 in TLR signaling, we first assessed cytokine production in response to various TLR ligands in DC subsets derived from wild-type and Pin1-deficient mice. When stimulated with the TLR4 ligand lipopolysaccharide (LPS), the TLR2 ligand tripalmitoyl cysteinylseryltetralysine (Pam 3 CSK 4 ), the TLR7 ligand resiquimod (R-848) or the TLR9 ligand CpG-B DNA (oligonucleotide 1826), Pin1-deficient myeloid DCs (mDCs) produced moderately less proinflammatory cytokines than did wild-type control cells (Fig. 1a-c) . Consistent with that, we also detected less secretion of proinflammatory cytokines from Pin1-deficient macrophages than from wildtype macrophages after stimulation with each of the TLR ligands ( Supplementary Fig. 1a,b) . Stimulation of splenic pDCs or cytokine Flt3L-induced bone marrow pDCs with purified ligand for TLR7 or TLR9 or with influenza A virus (subtype H1N1; a stimulator of TLR7) or mouse cytomegalovirus (MCMV; a stimulator of TLR9) resulted in robust secretion of IFN-α from wild-type cells (Fig. 1d-g ), as shown before 6, 26 . However, Pin1-deficient cells almost completely failed to produce type I interferons, as measured by enzyme-linked immunosorbent assay (ELISA) and quantitative RT-PCR (Fig. 1d-h ). These effects of Pin1 deficiency on IFN-α production were highly specific, as Pin1 deficiency affected neither the cell populations nor their TLR expression (Supplementary Fig. 2) . Moreover, Pin1 enzymatic activity, although not the amount of Pin1 protein, was much greater in human peripheral blood mononuclear cells stimulated with R-848 or CpG than in unstimulated cells (Fig. 1i) , consistent with the finding that Pin1 is kept inactivated until cellular cues are engaged 21, 27 . Thus, Pin1 has a moderate role in proinflammatory cytokine production in mDCs in response to various TLR ligands but is essential and specific for the type I interferon response in pDCs after ligation of TLR7 or TLR9.
Pin1 interacts with IRAK1 after TLR stimulation
To elucidate the molecular mechanisms that underlie the effect of Pin1 on the secretion of type I interferon, we used a proteomic approach to identify Pin1 substrates with a glutathione S-transferase (GST)-Pin1 affinity-purification procedure under high-salt and high-detergent conditions 22, 28 , a procedure that has been used to identify almost all known Pin1 substrates 21 . We used R-848-stimulated THP-1 cells, a human monocytic cell line that has a functional interferon response to ligands of TLR7 and TLR9 and can be cultured in sufficient volumes. After SDS-PAGE and mass spectrometry, we identified one prominent and reproducible Pin1-binding protein at 100 kDa as IRAK1 ( Fig. 2a and Supplementary Fig. 3a) . The Pin1-deficient phenotype was similar to that of IRAK1-deficient cells and mice 14, 20, 29 . Furthermore, similar to IRAK1 deficiency 14 , we found no obvious effect of Pin1 deficiency on IL-6 and IL-12p40 protein in pDCs stimulated with R-848 or CpG (Supplementary Fig. 1c,d) . We observed no difference in the secretion of IFN-β from wild-type and Pin1-deficient mDCs stimulated with CpG ( Supplementary Fig. 1e ), consistent with published results showing that stimulation of mDCs with CpG induces IFN-β production in a MyD88-and kinase IKKα-dependent but IRAK1-independent manner 29 . Those results prompted us to examine the role of Pin1 in regulating IRAK1 function in TLR signaling. We confirmed the TLR7-and TLR9-dependent interaction between IRAK1 and Pin1 in THP-1 monocytes and RAW264.7 mouse macrophages by a GST-Pin1 binding assay (Fig. 2b) and coimmunoprecipitation (Fig. 2c) . Pin1 bound mainly to the activated form of IRAK1, which after TLR ligation had a characteristic shift in mobility during migration through SDS gels (Fig. 2b,c) ; this suggested that Pin1 might bind specifically to phosphorylated IRAK1. Indeed, this binding A r t i c l e s was mediated by the Pin1 WW domain (Supplementary Fig. 3b,c) , a module known to bind phosphorylated Ser/Thr-Pro 28 , but was abolished either by dephosphorylation of IRAK1 before the Pin1-binding assay ( Fig. 2d and Supplementary Fig. 3d ) or substitution of a key functional residue in the WW domain 28 ( Supplementary Fig. 3b,e) . In addition, Pin1 did not bind to the related kinases IRAK2 and IRAK4 after stimulation via TLR7 and TLR9 (Supplementary Fig. 3f ). Thus, after ligation of TLR7 or TLR9, Pin1 is activated and IRAK1 is phosphorylated, which allows Pin1 to interact specifically with IRAK1. The binding of Pin1 to IRAK1 was somewhat unexpected, because Pin1 interacts only with specific phosphorylated Ser/Thr-Pro motifs 21, 28 and little is known about proline-directed phosphorylation of IRAK1 in TLR signaling 17 . Consequently, we sought to define the Pin1-binding region and site(s) in IRAK1. Structurally, IRAK1 consists of an N-terminal death domain, a proline-, serine-and threoninerich undetermined domain and a central kinase domain, with a C-terminal tail 17 (Supplementary Fig. 4a ). To avoid interference of endogenous IRAK1, we expressed Flag-tagged wild-type IRAK1 or IRAK1 mutants in IRAK1-deficient (I1A) human embryonic kidney 293 cells 30 , followed by a Pin1-binding assay. Overexpression of IRAK1 resulted in its autoactivation independently of TLR stimulation, as indicated by the characteristic shift in mobility, but expression of an IRAK1 mutant with an inactive kinase domain did not ('kinase-dead' IRAK1 (KD-IRAK1), with substitution of serine for lysine at position 239; Fig. 2e-g and Supplementary Fig. 4b ), as shown before 12, 13, 17 . IRAK1 interacted with Pin1, but KD-IRAK1 did not (Fig. 2e-h and Supplementary Fig. 4b) . Furthermore, deletion of the undetermined domain abolished binding to Pin1 (Supplementary Fig. 4b ). These data suggest that Pin1 binds to kinase-active IRAK1, possibly through autophosphorylation sites in the undetermined domain.
To demonstrate that Pin1 binds to autophosphorylated IRAK1, we coexpressed Flag-tagged KD-IRAK1 with or without wild-type IRAK1 in IRAK1-deficient cells, followed by analysis of the binding of Pin1 specifically to KD-IRAK1. As shown before 12 , KD-IRAK1 did not show the characteristic shift in mobility and failed to interact with Pin1 when it was expressed alone (Fig. 2e) . However, when
WT KD S110A S131A S144A S163A S173A S196A 3A A r t i c l e s coexpressed with wild-type-IRAK1, KD-IRAK1 showed the shift in mobility and also bound to Pin1 (Fig. 2e) , which suggested that Pin1 binds to autophosphorylated IRAK1. To confirm that Pin1 directly binds to IRAK1, we next did protein-protein immunoblot analysis with wild-type IRAK1 and KD-IRAK1 and GST-Pin1 WW. Indeed, Pin1 bound only to the slower 'mobility-shifted' and presumably activated form of wild-type IRAK1, but there was no binding of Pin1 to KD-IRAK1 (Fig. 2f) . Finally, to confirm binding of Pin1 to the active form of IRAK1, we did a Pin1-binding assay with mouse embryonic fibroblasts (MEFs) stably transfected with wild-type IRAK1 or KD-IRAK1 in the presence or absence of TLR7 activation. Pin1 bound to the active form of wild-type IRAK1 but not to KD-IRAK1 (Fig. 2g) , which confirmed that Pin1 binds mainly to activated IRAK1. Together these results indicate that after TLR ligation, IRAK1 is activated after being recruited to the receptor and then autophosphorylates its Ser-Pro motifs, which in turn recruits Pin1 to act on IRAK1.
To identify the IRAK1-phosphorylation site(s) responsible for binding Pin1, we substituted alanine for the serine residue in each of the six possible Pin1-binding phosphorylated Ser-Pro motifs in the undetermined domain of IRAK1 and assessed the binding to Pin1 expressed by retrovirus-transfected cells. All of the potential Pin1-binding sites in the undetermined domain were Ser-Pro motifs. Although substitution of Ser110, Ser163 or Ser196 had little effect on Pin1 binding, substitution of Ser131, Ser144 or Ser173 separately resulted in much less IRAK1 activation and Pin1 binding, which was further diminished when all three sites were substituted together (Fig. 2h) ; this indicated that phosphorylation of these sites participates in regulating IRAK1 activation and Pin1 binding. To confirm the phosphorylation status of these three sites, we used a two-step purification procedure to isolate IRAK1 with sequential Flag immunoprecipitation and GST-Pin1 precipitation, followed by liquid chromatography-tandem mass spectrometry. Ser131 and Ser144 were indeed phosphorylated ( Supplementary Fig. 5a,b) . However, digestion with trypsin or chymotrypsin repeatedly failed to produce any peptides that included the region surrounding Ser173 (Supplementary Fig. 5c ), possibly because of the many proline and hydrophobic residues in this region. This prompted us to generate an antibody specific for IRAK1 phosphorylated at Ser173. The resulting antibody specifically recognized activated wild-type IRAK1 but not the IRAK1 S173A point mutant, even when it was highly overexpressed and activated by transient transfection ( Supplementary  Fig. 6a) ; this confirmed that Ser173 in the undetermined domain of IRAK1 was indeed phosphorylated. Moreover, phosphorylation of IRAK1 at Ser173 was substantially induced in human peripheral blood mononuclear cells and THP-1 monocytes stimulated with R-848 or CpG, as determined by flow cytometry (Fig. 2i) and immunoblot analysis (Supplementary Fig. 6b ) with the antibody specific for IRAK1 phosphorylated at Ser173. Together these results indicate that after TLR activation, Ser131-Pro132, Ser144-Pro145 and Ser173-Pro174 motifs in the undetermined domain of IRAK1 not only are phosphorylated but also are largely responsible for binding of Pin1.
Pin1 acts on many phosphorylated Ser-Pro motifs in IRAK1
The WW domain and peptidyl-prolyl-cis-trans-isomerase (PPIase) domain of Pin1 have been shown to bind and isomerize, respectively, specific phosphorylated Ser/Thr-Pro motifs in its substrates 22, 28, 31 . To measure the interaction of Pin1 with each of the putatively involved phosphorylated Ser-Pro motifs in IRAK1, we used two-dimensional nuclear magnetic resonance spectroscopy to monitor the changes in a 15 N-labeled Pin1 WW domain induced by titration with ligands for the phosphorylated peptide. In the two-dimensional 15 N-1 H heteronuclear single quantum coherence spectrum of a protein, each backbone NH group is represented by a peak, whose position reflected the chemical environment of that NH bond. Binding of ligand to the protein is detected by changes in peak positions (fast exchange) or by the appearance of new peaks (slow exchange) as ligand is added. We measured the binding of the WW domain of Pin1 to each distinct IRAK1 site through the use of phosphorylated IRAK1 peptides containing residues 126-136 (phosphorylated Ser131-Pro132), 140-150 (phosphorylated Ser144-Pro145) or 157-180 (phosphorylated Ser173-Pro174) of IRAK1. The WW domain bound to each phosphorylated peptide and showed fast exchange kinetics, as demonstrated by changes in peak position, in each of the three titration experiments A r t i c l e s (Fig. 3a) . Quantitative analysis of the change in chemical shift as a function of peptide concentration (Fig. 3b) yielded dissociation constants of 220 ± 15 µM, 120 ± 12 µM and 260 ± 75 µM (mean ± s.d.), respectively, for the three phosphorylated peptides described above. The IRAK1-Pin1 interaction in the cell occurs as part of a multiprotein membrane-associated complex [12] [13] [14] , which suggests the potential for substantial binding enhancement due to avidity.
To determine whether Pin1 catalysis occurs at each of these sites, we used homonuclear two-dimensional rotating-frame Overhauser effect spectroscopy nuclear magnetic resonance as reported before 32 . In the presence of a catalytic amount of Pin1, we observed exchange cross-peaks between the cis and trans isomers of the phosphorylated Ser-Pro peptide bond for each peptide (Fig. 3c) . Conversely, in the absence of Pin1, exchange cross-peaks were missing (Fig. 3c) . These results demonstrate that Pin1 accelerates the cis-trans isomerization at each phosphorylated Ser-Pro motif, which thus confirmed these sites were Pin1 substrates.
Pin1 is essential for IRAK1 activation after TLR ligation
Given that Pin1 binds to and isomerizes many phosphorylated SerPro motifs in IRAK1 after TLR activation, a key issue was whether Pin1 regulates IRAK1 function in TLR signaling. Therefore, we examined the effects of Pin1 deficiency on IRAK1 activation in response to the activation of various TLRs in wild-type and Pin1-deficient MEFs and pDCs. Although ligation of TLR7 and TLR9 activated IRAK1 in a time-dependent way in both types of wild-type cells (Fig. 4a) , as indicated by the shift in mobility and greater kinase activity (Fig. 4b) , as described before 12, 13, 17 , there was no evidence of IRAK1 activation in Pin1-deficient MEFs or pDCs in either assay (Fig. 4a,b) or in THP-1 cells in which PIN1 was silenced by RNA-mediated interference (Fig. 4c) . Moreover, Pin1 deficiency also completely abolished IRAK1 activation in response to the ligation of other TLRs, including TLR2 and TLR4 (Supplementary Fig. 7a,b) . These effects were highly specific, because Pin1 deficiency did not affect activation of the IRAK1 upstream kinase IRAK4 (Fig. 4b) , or the mitogen-activated protein kinases Erk, Jnk and p38 after TLR activation ( Supplementary  Fig. 8 ). We obtained similar results for macrophages stimulated with LPS (Supplementary Fig. 9a ). We also assessed the effects of Pin1 deficiency on degradation of the inhibitor IκB after stimulation of pDCs with R-848 and CpG or treatment of macrophages with LPS and did not see any obvious difference between wild-type and Pin1-deficient cells (Supplementary Fig. 9b,c) . To further confirm this effect of Pin1 on IRAK1 activation, we developed an assay to measure the kinase activity of IRAK1 in cells based on the finding that IRAK1 phosphorylated a N-terminal 220-amino acid IRAK1 fragment containing the undetermined domain in trans, as shown by the characteristic shift in mobility after coexpression with wild-type IRAK1 (Fig. 4d) , as demonstrated before 12, 13, 17 . As expected, exogenously expressed IRAK1 in wild-type MEFs efficiently phosphorylated the IRAK1 N-terminal fragment, inducing the characteristic shift in mobility (Fig. 4d) . However, like KD-IRAK1, wild-type IRAK1 in Pin1-deficient MEFs completely failed to induce any shift in mobility of the N-terminal IRAK1 fragment (Fig. 4d) . These results together indicate that Pin1 is required for IRAK1 activation.
To further demonstrate the importance of Pin1 in the time-dependent activation of IRAK1 after TLR ligation, we overexpressed wild-type IRAK1and KD-IRAK1 in wild-type and Pin1-deficient MEFs with a retroviral expression system. Under overexpression conditions, wild-type IRAK1 was partially activated, and it was further activated after TLR7 ligation in wild-type cells, as shown by the characteristic shift in mobility (Fig. 4e) , consistent with the finding that IRAK1 activation is sensitive to the amount of IRAK protein 13, 17 . However, we observed no IRAK1 activation in Pin1-deficient cells, even after stimulation (Fig. 4e) , which further confirmed the role of Pin1 in IRAK1 activation. Notably, KD-IRAK1 did not show any evidence of activation after TLR ligation in either wild-type or Pin1-deficient cells (Fig. 4e) . These results indicated that IRAK1 was not activated in Pin1-deficient cells. To confirm that defective IRAK1 activation in Pin1-deficient cells was specifically due to the loss of Pin1 and to assess the importance of Pin1 binding and isomerase activities for IRAK1 activation, we did rescue experiments by re-expressing wild-type Pin1 or Pin1 with point substitution of alanine for the tryptophan at position 43 in the WW domain (Pin1(W34A)) or of alanine for lysine A r t i c l e s at position 63 in the catalytic domain (Pin1(K63A)), which fail to bind to or isomerizes Pin1 substrates, respectively 22, 28 . Re-expression of wild-type Pin1 completely restored IRAK1 activation in Pin1-deficient cells expressing IRAK1, but re-expression of Pin1(W34A), Pin1(K63A) or Pin1 PPlase domain alone did not (Fig. 4f) , reminiscent of the IRAK1 activation in Pin1 wild-type cells (Fig. 4e) . Together these results demonstrate an essential role for Pin1 in IRAK1 activation during TLR signaling.
Pin1 is essential for IRAK1-mediated IRF7 activation Given that Pin1 was required for activation of IRAK1, we sought to determine whether Pin1 regulates IRAK1-mediated downstream signaling. After activation of TLRs, IRAK1 is recruited via MyD88 and IRAK4 to the receptor complex, where it is activated and released from the receptor complex. This allows transcription factors such as IRF7, the master regulator of IFN-α, to translocate into the nucleus and activate transcription of the gene encoding IFN-α, which means IRAK1 activation is a key step in the TLR7-TLR9 signaling cascade [12] [13] [14] [15] [16] [17] [18] [19] . Therefore, we examined whether Pin1 deficiency affected the ability of IRAK1 to transduce TLR signals.
To determine whether IRAK1 was still recruited to the TLR receptor complex in Pin1-deficient cells, we transfected hemagglutinin-tagged MyD88 into both wild-type and Pin1-deficient cells that had retroviral expression of Flag-tagged IRAK1, followed by immunoprecipitation with antibody to hemagglutinin and then immunoblot analysis with antibody to Flag. As shown before 17 , we did not readily find the activated form of IRAK1 in wild-type cells in MyD88 immunoprecipitates (Fig. 5a) . However, IRAK1 in Pin1-deficient cells formed a stable interaction with hemagglutinin-tagged MyD88 (Fig. 5a) , presumably because IRAK1 was not fully activated in these cells (Figs. 4a and 5a) . Thus, it seemed that IRAK1 in Pin1-deficient cells was unable to dissociate from the receptor complex because of its lack of autophosphorylation 13, 17 , and presumably IRAK1 was retained at the receptor complex.
Given that Pin1 is required for IRAK1 activation and its dissociation from the receptor complex, we determined whether Pin1 affected IRF7 activation by knockdown and knockout of Pin1. Knockdown of Pin1 in THP-1 monocytes by RNA-mediated interference not only abolished the interaction of IRF7 and TRAF6, as shown by coimmunoprecipitation (Fig. 5b) , but also blocked the nuclear translocation of IRF7 in response to activation of TLR7 and TLR9, as determined by subcellular fractionation followed by immunoblot analysis (Fig. 5c,d ).
To further confirm those results, we immunostained IRF7 in wild-type and Pin1-deficient primary pDCs after ligation of TLR7 and TLR9. After TLR activation, IRF7 translocated to the nucleus in wild-type pDCs but not in Pin1-deficient pDCs (Fig. 5e) . These results suggested that Pin1 activated IRAK1 to cause nuclear translocation of IRF7 in response to stimulation of TLR7 or TLR9.
That idea was further supported by our findings obtained by IRAK1-mediated IRF7 functional assays. Specifically, Pin1 deficiency abolished IRF7 reporter activity after stimulation of TLR7 or TLR9 (Fig. 6a,b) , and those defects were fully 'rescued' by wild-type Pin1 but not by the Pin1(W34A) binding-inactive mutant or the Pin1(K63A) isomerase-defective mutant, as measured by IRF7 reporter activity and production of IFN-α (Fig. 6c,d) . To further investigate the role of Pin1 and the kinase activity of IRAK1 in IRF7 activation, we coexpressed MyD88, a reporter construct with IRF7 activated by the yeast transcriptional activator Gal4 (Gal4-IRF7), and various amounts of KD-IRAK1 in wild-type and Pin1-deficient MEFs. IRF7 activation in wild-type cells decreased as the amount of transfected KD-IRAK1 increased. In contrast, IRF7 activation was consistently lower in Pin1-deficient cells and was unaffected by the amount of KD-IRAK1 transfected (Fig. 6e) . These results demonstrated that both Pin1 and the kinase activity of IRAK1 were necessary for activation of IRF7. These findings are consistent with the published findings that IRAK1 phosphorylates IRF7, but its 'kinase-dead' mutant does not 14 ; that the kinase activity of IRAK1 is necessary for the transcriptional activity of IRF7 but not that of NF-κB 14 ; that 'kinase-dead' IRAK1 inhibits MyD88-induced IRF7 activation in a dominant-negative manner 14 ; and that inhibition of the kinase activity of IRAK with a synthetic inhibitor prevents IRF7 phosphorylation but not NF-κB phosphorylation in CpG-stimulated pDCs 33 .
IRAK1 substitutions that prevented the binding of Pin1 in retrovirus-transfected MEFs, including S131A, S144A and S173A alone or together, also resulted in less activation of the Irf7 promoter and less secretion of IFN-α, similar to KD-IRAK1 or Pin1 deficiency (Fig. 6f,g ). To confirm the importance of Pin1 in IRAK1-and IFN-α-mediated antiviral activity, we did plaque-formation assays with vesicular stomatitis virus (VSV) expressing green fluorescent protein (GFP). 
A r t i c l e s
We infected L929 mouse fibroblasts with GFP-expressing VSV and incubated the cells with supernatants of wild-type or Pin1-deficient MEFs expressing IRF7 and wild-type IRAK1 or various IRAK1 mutants, followed by quantification of GFP + plaques. Although supernatants of wild-type MEFs expressing wild-type IRAK1 had potent antiviral activity, those from wild-type MEFs expressing IRAK1 mutants had little activity, similar to Pin1-deficient MEFs (Fig. 6h,i) , consistent with the IRF7 activity and IFN-α production in these cells (Fig. 6f,g ). Thus, disrupting the IRAK1 activation by inhibiting Pin1 or by preventing IRAK1 from acting as a Pin1 substrate abrogated IRF7 activation, subsequent IFN-α production and antiviral responses in vitro.
Pin1 is required for IRAK1-IRF7-interferon-mediated immunity
Given the essential role of Pin1 on IRAK1-dependent antiviral cellular responses in vitro, we next examined the effects of Pin1 deficiency in vivo with wild-type and Pin1-deficient mice. After injecting mice with R-848 or CpG-A (oligonucleotide 1585) in complex with the cationic lipid DOTAP, we found robust IFN-α production in wild-type mice (Fig. 7a,b) , as shown before 14 . In contrast, serum IFN-α concentrations were lower in their Pin1-deficient littermates (Fig. 7a,b) . After injection of LPS or R-848, the serum concentrations of IL-6 and IL-12p40 were lower in Pin1-deficient mice than in wild-type control mice, albeit not as much as IFN-α ( Supplementary Fig. 10a-c) . As the MyD88-IRF7 pathway has been shown to be essential for IFN-α production during infection with MCMV 34-37 , we next examined the effect of Pin1 deficiency on systemic infection with MCMV. Whereas IFN-α concentrations in wild-type mice peaked at 36 h after MCMV infection, IFN-α induction was almost entirely suppressed in Pin1-deficient mice (Fig. 7c) . Moreover, Pin1-deficient mice were much more vulnerable to systemic infection with MCMV than were their wild-type littermates, which resulted in more weight loss (Fig. 7d) and morbidity (Fig. 7e) . These phenotypes were similar to those of IRF7-or Myd88-deficient mice [34] [35] [36] [37] and further emphasize the contribution of Pin1 to the antiviral immune response in vivo.
Costimulation of TLR9 and CD40 induces the population expansion of specific CD8 + T cells in a pDC-, IRF7-and IFN-α-dependent manner after exposure to antigen; thus, innate signaling pathways have a major role in regulating adaptive immune responses 19, 38 . To study the effects of Pin1 deficiency on adaptive immunity, we next investigated its effects on the induction of antigen-specific CD8 + T cell responses. As reported 19, 38 , treatment with ovalbumin and antibody to CD40 alone did not induce specific population expansion of CD8 + T cells, whereas coinoculation of CpG-A in complex with DOTAP, agonistic antibody to CD40 and ovalbumin induced substantial population expansion of antigen-specific CD8 + T cells in wild-type mice (Fig. 7f) . In contrast, the ovalbumin-specific CD8 + T cell response was considerably impaired in Pin1-deficient mice (Fig. 7f) .
The results reported above together indicated that Pin1 was essential for IRAK1 activation in response to stimulation of TLR7 and TLR9. After activation, Pin1 activity was upregulated and IRAK1 was autophosphorylated in the undetermined domain, which allowed Pin1 to bind to and isomerize phosphorylated IRAK1. Such Pin1-catalyzed conformational change facilitated the dissociation of IRAK1 from A r t i c l e s the receptor complex and recruitment of TRAF6, which combined with IRAK1 to activate IRF7 by promoting nuclear translocation for the induction of type I interferons to mediate innate and adaptive immunity (Supplementary Fig. 11a ). Pin1 deficiency specifically prevented IRAK1 activation and release from the receptor complex, which prevented recruitment of TRAF6 and activation of IRF7; this led to loss of the production of type I interferon and thereby inhibited type I interferon-dependent innate and adaptive immunity (Supplementary Fig. 11b ).
DISCUSSION
TLRs have an integral role in host defense against a broad range of microorganisms [1] [2] [3] , with TLR7 and TLR9 being particularly important components of the antiviral machinery [4] [5] [6] [7] . IRAK1 has been shown to be essential for TLR7-and TLR9-mediated induction of IFN-α [12] [13] [14] . However, the mechanisms that underlie the activation and regulation of IRAK1 are not well understood. Our results have demonstrated that Pin1 is a regulator of IRAK1, with an essential role in TLR signaling and type I interferon-mediated innate and adaptive immunity. Given the major role of aberrant IRAK1 activation and type I interferon overproduction in various immune diseases 10, 11 , our results suggest that inhibitors of Pin1, which are under development 21, 25 , may offer a useful therapeutic approach. We found that Pin1 activity was greater during TLR signaling and that deletion of Pin1 modestly inhibited TLR7-and TLR9-dependent proinflammatory cytokine production in mDCs but completely abrogated the production of type I interferon by pDCs. Consistent with those phenotypes, Pin1 specifically acted on IRAK1-autophosphorylation sites in a TLR-dependent manner. Mechanistic evaluation of the consequences of substitution of the Pin1-binding and Pin1-isomerization sites in IRAK1 or deletion of Pin1 demonstrated that the role of these phosphorylation sites is to promote a conformational change, leading to IRAK1 activation. Such Pin1-catalyzed conformational change facilitated the dissociation of IRAK1 from the receptor complex to activate downstream transcription factors for the induction of type I interferon. Specifically, Pin1 deficiency did not affect proximal IRAK1 signaling, as recruitment of IRAK1 to the TLR complex and activation of IRAK4 were normal. Furthermore, Pin1 deficiency did not affect other TLR-activated kinases, such as mitogenactivated protein kinases. However, Pin1 deficiency prevented the activation of IRAK1 and its release from the receptor complex, which led to loss of recruitment of TRAF6 to the complex and a failure of IRF7 to translocate to the nucleus. As a result, Pin1-deficient cells and mice failed to mount a robust systemic type I interferon response after treatment with R-848 or CpG or inoculation with MCMV and became very susceptible to viral infection. These results demonstrate an essential role for Pin1 in IFN-α-mediated innate immunity.
In addition to their central role in innate immunity, TLRs have profound effects on the ensuing adaptive immune response. Type I interferons not only limit viral replication but also exert various immunoregulatory effects, such as activation of B cells and T cells 39 , as well as maturation of mDCs 40 . Notably, after viral infection, type I interferons also enable cross-priming of CD8 + T cells, thereby allowing the presentation of exogenous antigens in the context of major histocompatibility complex class I molecules 38 . Pin1-deficient mice were defective in triggering antigen-specific CD8 + T cell responses. These results demonstrate a critical role for Pin1 in regulating IRAK1 and thus indicate a previously unknown mechanism positioned at the interface of innate and adaptive immunity.
The tight regulation of IRAK1 is probably needed to avoid inflammatory disease. For example, changes in the gene encoding IRAK1 are associated with pathological conditions such as systemic lupus erythematosus (SLE), which has led to the speculation that higher expression or constitutive activation of IRAK1 makes it a diseasesusceptibility factor for interferon-driven autoimmune disorders 41 . Similarly, more production of type I interferon has been intimately linked to many other autoimmune diseases 10, 11, 42 .
In particular, aberrant type I interferon signaling now has a demonstrated role in greater susceptibility to various viral infections, autoimmune diseases and cancer. Unifying themes of such diseases include the lack of treatment and the greater prevalence of these diseases in females. For example, women progress to AIDS much faster than do men who have the same viral load, and this has been attributed at least in part to substantial sex differences in IFN-α secretion that arise from stimulation of TLR7 by human immunodeficiency type 1 virus in DCs, which drives enhanced activity of CD8 + T cells 43 . Furthermore, the TLR-IRAK1-IRF7-type I interferon pathway is a key contributor to the pathogenesis of SLE, a disease that is particularly prominent in females 44, 45 . Specifically, in patients with SLE, higher concentrations of antibodies to self antigens such as nucleic acids activate TLRs to drive type I interferons, which then perpetrate autoimmune tissue destruction and pathogenesis 46 . Furthermore, genetic evidence has definitively associated components of the TLR-IRAK-IRF pathway with SLE 47 . A singlenucleotide polymorphism in IRAK1 has been associated with greater susceptibility to SLE, and IRAK1 deficiency effectively suppresses A r t i c l e s SLE in animal models 41 . These examples indicate the important roles of IRAK1 and type I interferons in a range of diseases. One of the challenges that has arisen from the wealth of knowledge on TLR signaling has been how to develop a strategy to inhibit specific arms of TLR-mediated immune regulation while leaving other critical defensive nodes untouched, a question no doubt asked by many biologists but rarely answered. Our data have shown that inhibition of Pin1 completely abrogated activation of IRAK1 and fully suppressed the production of type I interferon but had only moderate effects on proinflammatory cytokine production. These results suggest that inhibiting either Pin1 and/or the kinase activity of IRAK1 might allow pharmacological discrimination, which would allow selective inhibition of the type I interferon response while leaving proinflammatory cytokine production unaffected. Such a pharmacological approach might have advantages over conventional immunosuppression strategies.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
